Journal of Experimental Medicine, Vol 176, 565-573, Copyright © 1992 by Rockefeller University Press

ARTICLES

Systemic lupus erythematosus patients with central nervous system involvement show autoantibodies to a 50-kD neuronal membrane protein

VG Hanson, M Horowitz, D Rosenbluth, H Spiera and S Puszkin
Department of Pathology, Mount Sinai School of Medicine, New York, New York 10029.

An antibody was detected in the sera from patients with systemic lupus erythematosus (SLE) and central nervous system (CNS) involvement that reacted with a 50-kD antigen in the plasma membrane of brain synaptic terminals. The 50-kD antigen was solubilized with Triton X-100 from preparations enriched with synaptic plasma membranes, and was partially purified by molecular sieve filtration column chromatography. The sera of 19 of 20 CNS-SLE patients showed strong to moderate immunoreactivity with the 50-kD protein in Western blots. Immunoreactivity with the 50- kD protein was also detected in the cerebrospinal fluid of CNS-SLE patients. Control sera from healthy individuals did not react with the 50-kD protein. Low to background reactivity was detected in 35% of a group of SLE patients without CNS manifestations, and in 3% of patients displaying other connective tissue diseases. A total of 100 individuals were tested in this study. Purified autoantibodies to the 50-kD protein from CNS-SLE patients were used for immunofluorescent labeling of neuroblastoma cells. The immunofluorescent staining revealed a distinct macular distribution pattern on the surface of the cell membrane. Taken together, the data suggest that the 50-kD protein may be an important target for autoantibodies, preponderantly found in CNS-SLE patients, and that the antigen may play a role in the pathogenesis of some neurological manifestations in SLE.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Jennekens, F. G. I., Kater, L. (2002). The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation. Rheumatology (Oxford) 41: 619-630 [Abstract] [Full Text]  
• Brey, R. L., Holliday, S. L., Saklad, A. R., Navarrete, M. G., Hermosillo-Romo, D., Stallworth, C. L., Valdez, C. R., Escalante, A., del Rincon, I., Gronseth, G., Rhine, C. B., Padilla, P., McGlasson, D. (2002). Neuropsychiatric syndromes in lupus: Prevalence using standardized definitions. Neurology 58: 1214-1220 [Abstract] [Full Text]  
• Raymond, A., Zariah, A., Samad, S., Chin, C., Kong, N. (1996). Brain calcification in patients with cerebral lupus. Lupus 5: 123-128 [Abstract]  
• Mills, J. A. (1994). Systemic Lupus Erythematosus. NEJM 330: 1871-1879 [Full Text]  
• Hanly, J. G., Fisk, J. D., Eastwood, B. (1994). Brain Reactive Autoantibodies and Cognitive Impairment in Systemic Lupus Erythematosus. Lupus 3: 193-199 [Abstract]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS